Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,071 | -4,704 | -16,850 | -10,116 | -8,236 |
| Depreciation Amortization | 247 | 123 | 579 | 455 | 331 |
| Accounts receivable | -2,344 | -775 | -1,385 | -3,942 | -2,006 |
| Accounts payable and accrued liabilities | 316 | -860 | 2,859 | 1,142 | 1,284 |
| Other Working Capital | -1,291 | -533 | 2,558 | -3,937 | -2,336 |
| Other Operating Activity | 2,634 | 1,889 | -704 | 3,146 | 762 |
| Operating Cash Flow | $-9,509 | $-4,860 | $-12,944 | $-13,252 | $-10,202 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -193 | -90 | -808 | -772 | -545 |
| Investing Cash Flow | $-193 | $-90 | $-808 | $-772 | $-545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,250 | 4,125 | 6,210 | 5,085 | 3,960 |
| Debt Repayment | -641 | -587 | -3,373 | -2,713 | -220 |
| Common Stock Issued | 3,998 | N/A | 11,962 | 11,962 | 6,462 |
| Dividend Paid | -94 | -47 | -188 | -141 | -94 |
| Other Financing Activity | 0 | -22 | 0 | 0 | 0 |
| Financing Cash Flow | $11,513 | $3,469 | $14,611 | $14,193 | $10,108 |
| Exchange Rate Effect | 79 | 22 | 98 | 76 | 48 |
| Beginning Cash Position | 5,018 | 5,018 | 4,061 | 4,061 | 4,061 |
| End Cash Position | 6,908 | 3,559 | 5,018 | 4,307 | 3,471 |
| Net Cash Flow | $1,890 | $-1,459 | $958 | $246 | $-590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,509 | -4,860 | -12,944 | -13,252 | -10,202 |
| Capital Expenditure | -193 | -90 | -808 | -772 | -545 |
| Free Cash Flow | -9,702 | -4,950 | -13,752 | -14,024 | -10,746 |